chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Both arms cold; today its really bad; Nausea for three days; diarrhoea; not eating much; warm; Both arms tingly; Cold; Arm pain; weakness; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), DIZZINESS (dizziness), DIARRHOEA (diarrhoea), EATING DISORDER (not eating much) and VACCINATION SITE WARMTH (warm) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039b21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included Birth control, THYROID MEDS and Gastrointestinal medication for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced ASTHENIA (weakness), DIZZINESS (dizziness) and PAIN IN EXTREMITY (Arm pain). On 18-Apr-2021, the patient experienced DIARRHOEA (diarrhoea), EATING DISORDER (not eating much), VACCINATION SITE WARMTH (warm), PARAESTHESIA (Both arms tingly), NASOPHARYNGITIS (Cold) and NAUSEA (Nausea for three days). On 21-Apr-2021, the patient experienced FEELING ABNORMAL (today its really bad). On an unknown date, the patient experienced FEELING COLD (Both arms cold). At the time of the report, ASTHENIA (weakness), DIZZINESS (dizziness), DIARRHOEA (diarrhoea), EATING DISORDER (not eating much), VACCINATION SITE WARMTH (warm), PARAESTHESIA (Both arms tingly), NASOPHARYNGITIS (Cold), PAIN IN EXTREMITY (Arm pain), FEELING ABNORMAL (today its really bad) and NAUSEA (Nausea for three days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Non-significant Follow up- AE Contact Update On 25-May-2021: Non Significant Follow up appended for Document Attachment
tremors, spot @ 1st site, soreness, swelling @ 2nd site;
On day 8 after the shot I had a nickel size bump at the injection site.  By day 11 the spot had grown to 4 inches, was red and itchy.  It was also warm.  I took allergy medicine and by day 15 it had all cleared up.  Overall, the rash didn?t hurt but was annoying.
headaches get worse at night; headache; This is a spontaneous report from a contactable consumer. A 74-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration on left upper arm on 16Jan2021 14:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included anticoagulant therapy from an unknown date and unknown if ongoing. Concomitant medication included rivaroxaban (XARELTO). The patient had the first dose of the vaccine on 16Jan2021. He has had a headache that has come and gone and after taking over the counter medication they seem to have eased up a little. Saturday night was pretty bad and Sunday night he took Excedrin before he went to sleep and when he woke up he took another half and that seemed to keep it at bay. He took two halves today and it seems to be holding the headache back. He stated it feels more like an allergy headache, the left side of his temple by his left eye is where it radiates from. He asked if other people got headaches and how long do the headaches typically last and will they eventually go away. He reported his headaches were getting lighter, but the headaches get worse at night. The patient also stated when they give the shot they don't discuss the side effects. He said they give you a sheet that lists the side effects but he stated that 25% of people having headaches is pretty significant and this should be highlighted on the sheet. He said he took 1/2 of an Equate Headache Relief caplet, and then took another 1/2 of the Equate Headache Relief caplet later. He said he tried regular Tylenol (clarified as Equate brand Acetaminophen 500mg), and the Equate Acetaminophen 500mg didn't do anything for his headache. He stated he didn't have the Equate Acetaminophen 500mg box, any longer. Therapeutic measures were taken as a result of headache (headache). The outcome of the event headache was recovering while the event headaches get worse at night was unknown.
Shortly post 2nd dose, pt suffered from left knee pain. On 01/02/2000, he lost vision in left eye with on 50% returning. On 04/17, he experienced tingling in left arm and leg. On 07/27, he started to suffer from hip, knee and ankle pains in right leg. The annual report states scared optical nerve (poor vision).
Received mist 10/27/09 about 1:30 PM. At 6:30 PM, after football practice, had raised rash all over his body. Mom took to allergist-gave prednisone, BENADRYL and another antihistamine. Rash lasted about 5 days, came back if did not take antihistamines. Rash has been gone for 2 weeks except 1 spot last week. No other problems.
No additional adverse event reported; Expired vaccine used; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, drug reactions or allergies and concomitant medications were not reported.   On 23-FEB-2022, the patient was vaccinated with expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), 0.5 milliliter live recombinant human albumin (rHA) (Lot# T001215 and expiration date 12-JAN-2022), reconstituted with sterile diluent (Lot# T031063 and expiration date 27-DEC-2022) as prophylaxis (expired product administered). There was no previous temperature excursion. No additional adverse event reported, no further information provided.
Immune Thrombocytopenia Purpura; blood blisters in mouth; petechia; platelets were zero; This is a spontaneous report from a contactable consumer. A 60-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) dose 2 via an unspecified route of administration on 19Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE (at the age of 60 years old) for covid-19 immunisation.  Medical history included Multiple myeloma status post (s/p) CAR T therapy (Apr2020), on Pomalyst starting from Apr2020 to an unknown date.  Concomitant medications included pomalidomide (POMALYST) taken for an unspecified indication from Jan2021 to an unspecified stop date; acyclovir [aciclovir] (ACYCLOVIR [ACICLOVIR]) taken for an unspecified indication, start and stop date were not reported.   On 20Mar2021, the patient experienced immune thrombocytopenia purpura, blood blisters in mouth, petechia. In Mar2021, the patient experienced platelets were zero. Clinical course was as follows Immune Thrombocytopenia Purpura- About 24 hours after receiving the 2nd dose of the vaccine, started noticing blood blisters in mouth and petechia in 20Mar2021. Patient went to doctor on 22Mar2021 after 19Mar2021 vaccine and platelets were zero in Mar2021 and prednisone was started. Platelets were still 0 on 24Mar2021, and then was admitted to the hospital and was given steroids, IVIG, and Nplate. Now improvement. Of note, platelets were checked on 18Mar2021 and were 26, and then received 1 bag of platelets and they were not rechecked after. The patient underwent lab tests and procedures which included platelet: zero in Mar2021, platelet: 26 on 18Mar2021, platelet: were still 0 on 24Mar2021, Covid test: negative on unknown.  Therapeutic measures were taken as a result of immune thrombocytopenia purpura, blood blisters in mouth, petechia, platelets were zero. Outcome of the events was recovered.  Information about Batch/Lot number has been requested.
vaccine was given to patient and was expired by 1 day past the 10 week fridge expiration
Information has been received from a nurse referring to an unspecified number of unspecified patients. Nurse reported on unspecified dates since 24-DEC-2014, the patients were administered an unspecified number of improperly stored doses of RECOMBIVAX HB (dose, route and lot # not reported). No adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
23DEC97 pt exp runny nose & next day felt sick & had little energy, went to work late & left early;by 1JAN98 was bedridden & did not get u p for 4 days;had bad sinuses, coughing, bronchitis-like feeling, SOB, no voice;anemia;pleural effusio
Pt complained of itching in her arms, tongue and skin, had rash on arm, c/o chest tightness, some SOB, nausea, vomiting x1, leg spasms.  She was given 12.5mg IM Benadryl, EMS was called and they gave her one dose of SoluMedrol en route.  When she got to the ED she looked fine, and was just c/o leg cramps.
pt began having hives the day p/vax cont to have hives which are worsening to this date;hives throughout body;dermatologist identified this as an allerg rxn to hepatitis B vax;
Swelling at injection site; Itchy rash at injection site; Lymph node swelling in left armpit near injection site; Nausea; Fatigue; Low grade fever (100.1 F); Muscle soreness (throughout body, worst near injection site); Low energy; Headache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207), via an unspecified route of administration in the left arm on 06Apr2021 at 08:15 (at the age of 27-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic migraine, hemiplegic migraine, obesity, depression and anxiety. Concomitant medications included fremanezumab (AJOVY) autoinjector on 21Feb2021 and on 21Mar2021 administered in the stomach, levonorgestrel (MIRENA) from unknown date for unspecified indication, paracetamol (TYLENOL) from unknown date for unspecified indication, fluoxetine hydrochloride (FLUOXETINE) from unknown date for unspecified indication, magnesium aspartate (MAGNESIUM) from unknown date for unspecified indication and melatonin (MANUFACTURER UNKNOWN) from unknown date for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), via an unspecified route of administration in the left arm on 16Mar2021 at 09:30 (at the age of 27-years-old), as a single dose for COVID-19 immunisation. The patient previously took WELLBUTRIN on unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 02:00, the patient experienced swelling and itchy rash at injection site, lymph node swelling in left armpit near injection site, nausea, fatigue, chills, low grade fever (100.1 F), muscle soreness (throughout body, worst near injection site), headache and low energy. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 07Apr2021 at 02:00, the patient underwent lab test and procedure which included body temperature and result was shown as 100.1 F. The clinical outcome of the events swelling and itchy rash at injection site, lymph node swelling in left armpit near injection site, nausea, fatigue, chills, low grade fever (100.1 F), muscle soreness (throughout body, worst near injection site), headache and low energy were resolving at the time of reporting.   No follow-up attempts are needed. No further information is expected.
pt recv vax 19DEC97 & 12MAR98 parent reported pt had a fever of 105 p/vax-reportedly w/in 48hr of receiving vax;
Exceptionally sever bleeding from a very small dog bite (actually a nip) that took only one stitch to close, large amount of blood loss.
A report was received from a health professional on 22Oct02, concerning a vaccinee of unk demography who experienced nausea after receiving Fluvirin on an unk date. The vaccinee developed  nausea on an unk date. The vaccinee received a previous Flu vaccine with no adverse effects.  It was unk if the vaccinee had recovered.  There was insufficient information to determine the reporters causality assessment. Ref: PJP200200645; PJP200200649.
This spontaneous report was received from a registered nurse via physician and medical assistant regarding a patient of unknown age and gender. The patient's medical history, current conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of ROTATEQ lot # M035456 with expiry date 01-MAY-2018, (strength, dose and route of administration were not reported) for prophylaxis. The vaccine was exposed to 31 Fahrenheit degree (F) or colder (25F) for 1 hour 53 minutes and 47 Fahrenheit degree (F) to 77 Fahrenheit degree (F) (49F) for 3 hours 59 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse effects reported. There was no product quality complaint (PQC) involved. This is one of the several reports received from same reporter.; Sender's Comments:  US-009507513-1708USA003308: US-009507513-1709USA011730: US-009507513-1709USA011731: US-009507513-1709USA011733: US-009507513-1709USA011734:  US-009507513-1709USA011735: US-009507513-1709USA011736: US-009507513-1709USA011737: US-009507513-1708USA003070:
Patient received Covid-19 vaccine dose #1. Patient developed tongue tingling approximately 45 min after vaccine. Zyrtec 10 mg po given. patient then reported chest tightness and SOB, epi 0.3mg given and 911 called. Patient transported to ER via ambulance in stable condition.
Information has been received from a registered nurse certificated concerning a 22 year old female patient with no significant past medical history and no concurrent medical conditions who on 19-SEP-2008 was vaccinated with the first dose of GARDASIL (Lot # 660620/0571X). No concomitant medication was reported. On 19-NOV-2008 was vaccinated with the second dose of GARDASIL (Lot # 661044/0548X). On 20-JAN-2009, an ultrasound was performed for dating which showed single live intrauterine pregnancy (SLIUP), 12 weeks, 2 days. (LMP 31-OCT-2008, EDD 07-JUL-2009). A MSAFP was declined by the patient. Follow up information was received from a registered nurse certified. She reported that on 08-AUG-2009, at 40 1/7 weeks from LMP, the patient gave birth to a normal male infant with no congenital anomalies weighing 8 pounds and 0 ounces, apgar score 9/9. It was reported that the patient required a c-section for fetal bradycardia due to cord compression (cord pH 7.257). There were no other complications during pregnancy neither infections nor illnesses. Laboratory testing during pregnancy included routine screening (results not provided). Upon internal review c-section, fetal bradycardia and cord compression were determined to be other important medical events. Additional information has been requested.
12/19/2021: Patient seen and examined for shortness of breath.  On arrival to the ED.  Patient was hypoxic, with increased work of breathing, AOx4.  On nasal cannula liters per minute.  Saturations 85%.  Patient was immediately placed on BiPAP which improved his work of breathing and his oxygen saturations.  Concern for worsening COVID-19  Admitted to critical care.  Remains in ICU currently., on Jan 5 2022- Hospital day 16
Mother states one week post vax, the pt developed a raised rash on upper body with itching. Mother used calamine lotion. Some peeling around rash was noted. No physician was available at that time of morning. Mother stated she would take child to PMD.
Reported to me over the phone:The night of the vaccination the left arm became very painful and swollen.  The next day the swelling continued into armpit, noticed chills from waist down and a decrease in ROM with weakness.
feeling of warmth in arms; recvd HBIG vax plus Engerix-B; arm movements nl under poss allergic phenomena;
Mom phoned BOH states patient has itching and mild swelling in (L) arm at insertion site. Sent picture to BOH. Hive like swelling noted, mom said it looked like the size of a Snickers bar. Encouraged BENADRYL and TYLENOL. Continue to watch for increase in size or reaction.
Fever; Cough; sick; This is a spontaneous report received from a non-contactable consumer (reporting on herself) Via Pfizer Sponsored Program COVAX Support.   A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL1041 and Expiration Date was not reported), via an unspecified route of administration on 31Dec2020 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that patient experienced fever and cough. Patient did not provide any of her information since she wants to talk to someone since she was sick she received her first dose on 29Mar2021 (Further clarification unknown), and scheduled for second dose tomorrow 26Apr2021. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Intense chills, followed by body aches, joint aches, fever 100-101, severe nausea preventing any oral intake that day, in addition to the expected soreness in the arm.
Pt recvd vax 14OCT & on 15OCT woke w/fever, 17OCT progressing to severe n,v; taken to ER told it was not vax; also has UTI & was put on ATB;
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information about the patient pertinent medical history, concurrent medications and drug reactions or allergies was provided. On an unknown date, the patient was vaccinated with improperly stored dose of VAQTA (dose, dose number, route of administration, lot# and expiration date were not provided). On 12-JAN-2018, the the patient was re-vaccinated with a dose of VAQTA dose, dose number, route of administration, lot# and expiration date were not provided). No adverse event was reported. This is one of a several reports received from the same reporter.
Fatigue, nausea, upset stomach, headache, possible fever, and chills. Occurred from 3pm the day following the injection until going to sleep (approx. midnight). Treated with two Advil and one Benadryl.
Fever, chills, nausea, joint pain, body aches, swollen lymph node; swollen, red, hot to touch at injection site. Began 4 hours after shot and ended 8 am Sunday morning.
Symptoms included headache, extreme fatigue, nerve pain, tingling and numbness on the left side of my body (including face, head, neck, shoulder, arm, hand), feeling of swelling in eye lids (but no visible swelling), pain in and behind my left eye accompanied with pain in left temple, slight vision change (blurriness) in my right eye.  These symptoms began 3 days after I received my booster.  The symptoms lasted for 6 weeks.
Pain at vaccine site and  growing inflammation, spreading  to a red swollen circle roughly 6cm in diameter over the course of 60 hours (at time of writing) No  bodily fever, dizziness, or systemic hives.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness of arm) and PAIN (A few days later he had soreness all over did not go away for couple of days) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017F21A) for COVID-19 vaccination. The patient's past medical history included Polymyalgia rheumatica (Was treated for two years with Prednisone and was resolved itself after about 2 years) in 2013. Previously administered products included for Product used for unknown indication: COVID-19 Vaccine J&J (First Dose of COVID-19 vaccine J & J, Intramuscular) on 07-Mar-2021 and Flu vaccine (Received flu vaccine last year.) in 2021. Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine J&J and Flu vaccine. Concurrent medical conditions included Seafood allergy (Seaweed salad allergy). Concomitant products included Warfarin; Lisinopril; Rosuvastatin; Hydrochlorothiazide; Multivitamins [Vitamins NOS] for an unknown indication. On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness of arm) and PAIN (A few days later he had soreness all over did not go away for couple of days). At the time of the report, PAIN IN EXTREMITY (soreness of arm) and PAIN (A few days later he had soreness all over did not go away for couple of days) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, C-reactive protein: 12 or 13 (High) C reactive poteen spiked to 12 or 13 for about 4 months. The patient called to report adverse event after receiving the Moderna booster dose. The patient reported that after the booster the patient expected soreness in arm which the patient had then a few days later the patient had soreness all over did not go away for couple of days. The patient also stated that the patient had quarterly blood work done from primary care physician and based on bloodwork results panel for C reactive protein spiked to 12 or 13 for about 4 months. The patient said that this never had spiked, and the level was supposed to be less than 8 and was always lower for years. The patient reported that it took until Feb-2022/Mar-2022 for C reactive protein to lower again. The patient's height was 6 ft. 3 in. No treatment information was provided.
Body aches; Joint pain; Vaccination site pain and soreness; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 13Apr2021 at 10:15 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergy. The patient previously took amoxicillin on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) and allergy shots from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 12:00 the patient experienced body aches and joint pain for 24 hours, injection site pain and soreness for 4days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, joint pain were recovered on15Apr2021. The clinical outcome of the event injection site pain and soreness was recovered on 17Apr2021.   No follow-up attempts are needed. No further information is expected.
Pt is a 26 yo male, s/p full Pfizer vaccination: dose 1 on 12/18/2020 and dose 2 on 1/13/2021. Pt is an employee at this institution. PMH for carcinoid tumor in remission. Recent exposure to COVID positive individuals. On 8/6, reports small cough, achiness, then quick onset of lightheadedness, headache, nausea, SOB, fever of 102, and tachycardia. COVID test results back positive. No acute cardiopulmonary findings. Received IV fluid hydration, acetaminophen, guaifenesin, ketorolac, ondansetron. Discharged later that day.